Six-Month Response to Delamanid Treatment in MDR TB Patients.
Emerg Infect Dis
; 23(10)2017 10.
Article
in En
| MEDLINE
| ID: mdl-28767036
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oxazoles
/
Tuberculosis, Multidrug-Resistant
/
Nitroimidazoles
/
Antitubercular Agents
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Female
/
Humans
/
Male
Language:
En
Journal:
Emerg Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2017
Document type:
Article
Country of publication:
Estados Unidos